Insider sale notice: Quantum Biotechnologies (NASDAQ: QUBT) files to sell 9,360 shares

Rhea-AI Filing Summary

Quantum Biotechnologies (QUBT) filing to sell 9,360 shares. The Form 144 reports the intended sale of 9,360 shares following an exercise of options under a registered plan dated 03/11/2026. The filing also shows prior sales of 68,902 shares on 03/10/2026.

Insights

Securities Compliance Counsel

Form 144 notifies of a planned disposition after option exercise.

The filing lists an intended sale of 9,360 shares on 03/11/2026 tied to an exercise of options under a registered plan. This is a regulatory notice that certain resale conditions and holding-period rules may apply.

Prior sales of 68,902 shares on 03/10/2026 are reported; subsequent filings will confirm actual settlement and any proceeds. Cash‑flow treatment and purchaser identity are not specified in the provided excerpt.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9360	73494.72	224538254	03/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Exercise of options under a registered plan	Issuer			9360	03/11/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER ROBERTS 5 Marine View Plaza Suite 214 Hoboken NJ 07030	Common	03/10/2026	68902	541004.72

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did QUBT disclose in this Form 144?

The filing discloses an intended sale of 9,360 shares following an option exercise dated 03/11/2026. It also reports prior sales of 68,902 shares on 03/10/2026, as shown in the excerpt.

Who appears to be the selling party in the QUBT Form 144?

The excerpt names an address associated with a filer and lists the sale as occurring under an issuer-registered plan. The filing links the sale to an exercise of options under a registered plan dated 03/11/2026 in the excerpt.

Does the Form 144 show how many shares were sold recently for QUBT?

Yes. The filing shows recent sales of 68,902 shares on 03/10/2026 in the "Securities Sold During The Past 3 Months" section of the excerpt provided.

Is the 9,360-share amount in QUBT's Form 144 the result of an option exercise?

Yes. The excerpt specifies the intended sale of 9,360 shares is tied to an exercise of options under a registered plan with the transaction date listed as 03/11/2026.

Will this Form 144 confirm the actual sale of QUBT shares?

No. Form 144 notifies an intent to sell; it does not by itself confirm settlement. The excerpt reports intended and recent transactions; later filings or broker records would confirm final sale details.